JP Morgan Private Wealth Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-16,650
Closed -$1.31M 1821
2020
Q4
$1.31M Buy
+16,650
New +$977K ﹤0.01% 895
2020
Q1
Sell
-6,248
Closed -$443K 1573
2019
Q4
$443K Buy
6,248
+258
+4% +$18.7K ﹤0.01% 1095
2019
Q3
$448K Buy
5,990
+69
+1% +$5.85K ﹤0.01% 1040
2019
Q2
$477K Buy
5,921
+1,954
+49% +$137K ﹤0.01% 1006
2019
Q1
$265K Buy
+3,967
New +$300K ﹤0.01% 1270

Other funds holding CMD

JP Morgan Private Wealth Advisors's CMD Position: Q1 2021 in Review

JP Morgan Private Wealth Advisors sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 16,650 shares — an estimated $1.31M sold.

JP Morgan Private Wealth Advisors first reported a position in CMD in Q1 2019 and held it in 5 quarters. The position peaked at $1.31M in Q4 2020. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • JP Morgan Private Wealth Advisors reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 16,650 Cantel Medical Corporation shares in Q1 2021, an estimated $1.31M.
  • JP Morgan Private Wealth Advisors first reported a position in Cantel Medical Corporation in Q1 2019 and held it in 5 quarters.
  • JP Morgan Private Wealth Advisors's Cantel Medical Corporation position peaked at $1.31M in Q4 2020.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2021, filed 14 May 2021.